Umbral Energy Corp. 

acquiring assets, unlocking value.

The Company participates, through identification and strategic alliances, for opportunities to increase shareholder value with focus on growth and cash flow.

  • Acquire assets utilizing the networking capabilities of our principals
  • Taking advantage of opportunities for good assets in under capitalized situations
  • Prudent expenditure of capital in developing moderate-risk projects
  • Increase the significance of the acquired assets and create capital growth
  • Access sources of funding to drive Company growth.

The Company is currently listed as a junior resource issuer having mineral exploration projects.  The Company is considering other activities to increase shareholder value, including non-resource projects.

The Company has a mineral exploration projects in Utah, Nevada and Quebec.  

In addition Umbral has an interest in PhyeinMed, who has applied for a license from Health Canada to legally grow and sell medical marijuana.  The board of Directors has approved the Company’s plan to enter the medical marijuana business and its general plan to diversify its business into other industry sectors outside of the mining resource sector with a view of creating value for shareholders. The Company confirms that the Acquisition is not a Fundamental Change, as defined in Policy 8 of the Canadian Securities Exchange. However, if the Acquisition results in a Fundamental Change, the approval of the Company’s shareholders is required. There can be no assurance that the Acquisition or any other transactions for the Company’s prospective projects in the medical marijuana industry will be successfully completed.

Ability to Explore, Develop, and Operate.

Umbral Energy Corp. is an exploration and development company with a focus on becoming a low cost supplier for the burgeoning energy industry.

Email List

Latest ‍‍‍News

Read More

Umbral Energy Corp. is a resource exploration company, management will continue to review opportunities to increase shareholder value.

Jag Bal, President & CEO

Umbral Energy Corp.

929 Mainland St.
Vancouver, BC V6B 1S3

604-628-1767

Copyright All Rights Reserved © 2016

Documents and information

click on the following link:
Documents filed on SEDAR

Share price information 
click on the following link:  
CSE Trading Symbol| UMB

OTC trading symbol | UMBBF

ISSUED AND OUTSTANDING 131,491,972‍‍‍

Home

Corporate

Projects

News

Investors

Contact Us

Umbral assigns interest in Tule Valley, Utah and Gerlach, NV Lithium Projects

Vancouver, B.C., April 7, 2017– UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral” or “Company”) is pleased to announce that further to the news release of February 17, 2017, the Company has assigned its 100% interest in the Tule Valley, Utah and the Gerlach, Nevada lithium brine properties.

UMBRAL COMPLETES OFFER TO PURCHASE PROPERTY

Vancouver, B.C., May 10, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) and the management of PhyeinMed Inc. (“PhyeinMed”) a Health Canada Stage 5 applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations) are pleased to announce the completion and acceptance of the offer to purchase the property in Falkland, BC for the purposes of cannabis production.

Incentive Stock Option Grant

Vancouver, B.C., June 21, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) announces, that it has granted a total of 500,000 incentive stock options to directors/officers/employees and/or consultants under the Company’s Stock Option Plan. The options are exercisable at $0.055 per share and will expire June 21, 2022. Following this grant of options, the Company has 3,050,000 stock options outstanding.

July 5, 2017 - UMBRAL ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE ADDITIONAL 25% INTEREST IN LATE STAGE ACMPR APPLICANT PHYEINMED AND PROVIDES CORPORATE UPDATE

July 6, 2017   UMBRAL ACMPR APPLICANT PHYEINMED PREPARES TO EXPAND TO OVER 420,000 SQUARE FEET

UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral or Company”) and the management of PhyeinMed Inc. (“PhyeinMed”) a late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations) are pleased to announce that planning and preparations have begun to build a 420,000 square foot cannabis production facility consisting of two buildings on 13 acres of land in Falkland, British Columbia.

UMBRAL COMPLETES THE SUBJECT REMOVAL FOR THE PURCHASE OF THE FALKLAND PROPERTY

Vancouver, B.C., July 13, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral or Company”) and the management of PhyeinMed Inc. (“PhyeinMed”) a late stage applicant under the ACMP (Access to Cannabis for Medical Purposes Regulations) are pleased to announce it has paid the second instalment of $75,000 on its targeted acquisition in Falkland, BC.

UMBRAL ANNOUNCES NON-BROKERED UNIT PRIVATE PLACEMENT

Vancouver, B.C., July 14, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral or Company”) announcesthat non-brokered private placement consisting of up to 34,000,000 units (the “Units”) at a purchase price of $0.06 per Unit to raise gross proceeds of up to $2,040,000 (the “Private Placement”).

START UP MATERIALS SECURED FOR PRODUCTION

Vancouver, B.C., July 20, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral or Company”) on behalf of the management of PhyeinMed Inc. (“PhyeinMed”), a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Re‍‍‍gulations), announces that it has signed an agreement with CanGenX BioTech Inc. (CanGenX) to undertake plant tissue culture as its production basis.

UMBRAL ENERGY CORP. | ANNUAL GENERAL MEETING

Vancouver, B.C., July 26, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral or Company”) is pleased to advise, at the Umbral Energy Corp’s annual general meeting held on July 7, 2017, shareholders of the company approved all the items

UMBRAL’S SUBSIDIARY PHYEINMED JOINS THE CANOPY GROW FAMILY

Vancouver, B.C., August 8, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral or Company”) is pleased to announce that its 75% owned subsidiary, PhyeinMed Inc. (“PhyeinMed”) a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations) has signed an agreement with Canopy Growth Corporation (TSX:WEED) (“Canopy Growth”) to supply cannabis products via the CraftGrow line on Tweed Main Street’s online store.

Incentive Stock Option G‍‍‍rant

Vancouver, B.C., August 16, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) announces, that it has granted a total of 2,000,000 incentive stock options to Debra Senger.Debra is the President and CEO of PhyeinMed Inc. The options are exercisable at $0.10 per share and will expire August 16, 2022.

UMBRAL COMPLETES ACQUISITION OF ADDITIONAL 25% INTEREST IN LATE STAGE ACMPR APPLICANT PHYEINMED AND ADOPTION OF RESTRICTED SHARE UNIT PLAN

Vancouver, B.C., August 21, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) is pleased to announce that further to its press release dated July 5, 2017, and pursuant to a share purchase agreement dated effective June 21, 2017 (the “SPA”) among Umbral, its wholly-owned subsidiary 1005477 B.C. Ltd., Estek Ventures Corp. (the “Vendor”) and Debra Senger (“Senger”), the Company has acquired an additional 25% interest (the “Acqusiition”) in PhyeinMed Inc. (“PhyeinMed”), a late stage Health Canada Access to Cannabis for Medical Purposes Regulations (“ACMRP”) applicant for the purpose of growing, selling and distributing medical cannabis.The Company now owns 75% of the issued and outstanding common shares of PhyeinMed while the Vendor retains a 25% interest.

Further to the news release dated July 14, 2017, the non-brokered private placement consisting of 34,000,000 units at a purchase price of $0.06 per unit is expected to close August 23, 2017 over subscribed.

UMBRAL ANNOUNCES INCREASE TO PRIVATE PLACEMENT DUE TO SIGNIFICANT INTEREST

Vancouver, B.C., August 24, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) is pleased to announce that due to investor demand, it is increasing the maximum amount to be raised under its previously announced non-brokered private placement of units to $2,622,000 (the “Offering”).

UMBRAL ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Vancouver, B.C., August 31, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) is pleased to announce that it has closed its previously announced (see press releases dated July 14, 2017 and August 24, 2017) non-brokered private of 43,700,000 units (the “Units”) at a price of $0.06 per Unit for gross proceeds of $2,622,000 (the “Offering”).

UMBRAL COMPLETES EARLY CLOSE ON FALKLAND FACILITY

Vancouver, B.C., September 5, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral or Company”) is pleased to announce that it has‍‍‍ completed the final payment one month early on the purchase of the Falkland, BC property as previously announced on May 10, 2017. The final payment of $895,000 plus closing costs was completed August 31, 2017, and the company now has full access to the property.